Haruka Kuriyama Selected Research

Proteins (Proteins, Gene)

4/2021	Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
11/2020	Methyl-CpG binding domain protein 3: a new diagnostic marker and potential therapeutic target of melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haruka Kuriyama Research Topics

Disease

13	Melanoma (Melanoma, Malignant) 01/2024 - 01/2019
6	Neoplasms (Cancer) 01/2023 - 01/2020
1	Uveitis 11/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023
1	Inflammation (Inflammations) 09/2021
1	Disseminated Intravascular Coagulation 06/2020
1	Experimental Melanoma 01/2020
1	Brain Abscess (Abscess, Brain) 01/2019
1	Hemangiosarcoma (Angiosarcoma) 01/2019
1	Colitis 01/2019
1	Skin Diseases (Skin Disease) 08/2014

Drug/Important Bio-Agent (IBA)

4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 06/2021
4	NivolumabIBA 01/2024 - 01/2019
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 06/2021
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 11/2020
2	Peptides (Polypeptides)IBA 02/2021 - 01/2020
2	AntigensIBA 02/2021 - 01/2020
1	InterferonsIBA 01/2024
1	pembrolizumabIBA 01/2024
1	dabrafenibIBA 01/2024
1	trametinibIBA 01/2024
1	LigandsIBA 10/2023
1	ChemokinesIBA 10/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2021
1	Early Growth Response Protein 1IBA 09/2021
1	Cell-Free Nucleic AcidsIBA 06/2021
1	Interleukin-15 Receptor alpha SubunitIBA 05/2021
1	Interleukin-15 (Interleukin 15)IBA 05/2021
1	Interferon-betaIBA 05/2021
1	Nucleosomes (Nucleosome)IBA 04/2021
1	CytokinesIBA 02/2021
1	EpitopesIBA 02/2021
1	Small Interfering RNA (siRNA)IBA 11/2020
1	IpilimumabIBA 06/2020
1	OvalbuminIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	OX40 LigandIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	cadherin 5IBA 08/2014

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2019
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 02/2021
3	Immunotherapy 01/2023 - 01/2020
1	Aftercare (After-Treatment) 02/2021
1	Injections 02/2021
1	Radiotherapy 01/2019